Tiludronic acid manufacturers
- Tiludronic acid
-
- $0.00 / 25KG
-
2023-10-11
- CAS:89987-06-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Tiludronic acid
-
- $0.00 / 1KG
-
2023-09-06
- CAS:89987-06-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 500000kg
|
| | Tiludronic acid Basic information |
| Product Name: | Tiludronic acid | | Synonyms: | [[(4-Chlorophenyl)thio]methylene]bisphosphonic acid;ACPMD;C1-TMBP;ME-3737;Tiludronate disodium salt hydrate;Tiludronic acid disodium;Tilundronic Acid;TILUDRONIC ACID | | CAS: | 89987-06-4 | | MF: | C7H9ClO6P2S | | MW: | 318.61 | | EINECS: | | | Product Categories: | API | | Mol File: | 89987-06-4.mol |  |
| | Tiludronic acid Chemical Properties |
| Melting point | 174-177 °C | | Boiling point | 600.7±65.0 °C(Predicted) | | density | 1.82±0.1 g/cm3(Predicted) | | storage temp. | room temp | | solubility | H2O: >10mg/mL, clear | | pka | pK1 10.85; pK2 6.90; pK3 2.95; pK4 1.30(at 25℃) | | form | powder | | color | white to off-white |
| | Tiludronic acid Usage And Synthesis |
| Definition | ChEBI: Tiludronic acid is an organochlorine compound. | | Veterinary Drugs and Treatments | Tiludronate disodium (tiludronic acid) is a bisphosphonate bone
resorption inhibitor that is available in some countries for the intravenous
treatment of navicular disease in horses. Treatment earlier
in the course of the disease apparently results in greater efficacy.
For humans, there is an orally administered FDA-approved
product for treating Paget’s disease (osteitis deformans). |
| | Tiludronic acid Preparation Products And Raw materials |
|